Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness
Journal
Acta psychiatrica Scandinavica
Journal Volume
131
Journal Issue
3
Date Issued
2015-03
Author(s)
Wu S.-I.
Kao K.-L.
Chen S.-C.
Lin C.-J.
Fang C.-K.
Dewey, M
Prince, M J
Stewart, R
Abstract
To investigate the association between acute myocardial infarction (AMI) and recent exposure to antipsychotic agents in people with serious mental illness (SMI), and modifying influences.
Subjects
acute myocardial infarction; antipsychotic; bipolar disorder; schizophrenia; serious mental illness
Acute myocardial infarction; Antipsychotic; Bipolar disorder; Schizophrenia; Serious mental illness
SDGs
Other Subjects
aripiprazole; chlorpromazine; chlorprothixene; clozapine; flupentixol; fluphenazine; haloperidol; levomepromazine; melperone; neuroleptic agent; olanzapine; periciazine; pimozide; pipamperone; prochlorperazine; promazine; quetiapine; sulpiride; thioridazine; ziprasidone; zuclopenthixol; neuroleptic agent; acute heart infarction; adult; Article; bipolar disorder; cardiovascular risk; controlled study; crossover procedure; disease association; drug exposure; female; human; major clinical study; male; mental patient; national health insurance; priority journal; risk assessment; schizophrenia; vulnerable population; aged; bipolar disorder; case control study; chemically induced; middle aged; Myocardial Infarction; risk factor; schizophrenia; Taiwan; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Case-Control Studies; Cross-Over Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Schizophrenia; Taiwan
Type
journal article